Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Minerva Neurosciences: NERV

14 Posts
| Omlaag ↓
  1. [verwijderd] 23 maart 2017 13:28
    Zacks: Analysts Set $17.00 Target Price for Minerva Neurosciences Inc (NERV)

    March 23rd, 2017 - By Amy Steele - 0 comments

    Minerva Neurosciences logoShares of Minerva Neurosciences Inc (NASDAQ:NERV) have received a consensus broker rating score of 0.00 () from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.

    Brokers have set a one year consensus price objective of $17.00 for the company and are expecting that the company will post ($0.30) EPS for the current quarter, according to Zacks. Zacks has also given Minerva Neurosciences an industry rank of 108 out of 265 based on the ratings given to its competitors.

    A number of analysts have recently issued reports on NERV shares. Zacks Investment Research upgraded Minerva Neurosciences from a “sell” rating to a “hold” rating in a report on Friday, March 17th. Jefferies Group LLC started coverage on Minerva Neurosciences in a report on Monday, March 6th. They set a “buy” rating and a $17.00 target price for the company.
14 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 918,72 -0,64%
EUR/USD 1,0706 -0,31%
FTSE 100 8.146,86 -0,21%
Germany40^ 18.004,30 -1,43%
Gold spot 2.332,68 0,00%
NY-Nasdaq Composite 17.688,88 +0,12%

Stijgers

UNILEV...
+0,76%
KPN
+0,75%
DSM FI...
+0,73%
NSI
+0,72%
Vastned
+0,65%

Dalers

EBUSCO...
-6,53%
Avantium
-4,28%
SIGNIF...
-3,78%
ALLFUN...
-3,55%
BESI
-3,52%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links